Orasure Technologies Inc. (OSUR) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Orasure Technologies Inc. (OSUR:NASDAQ), powered by AI.

Current Price
$4.32
P/E Ratio
-4.6
Market Cap
317M
Sector
Healthcare
What is the Orasure Technologies Inc. stock price forecast?

Orasure Technologies Inc. is currently trading at $4.32. View real-time AI analysis on Alpha Lenz.

What is Orasure Technologies Inc. insider trading activity?

View the latest insider trading data for Orasure Technologies Inc. on Alpha Lenz.

What is Orasure Technologies Inc.'s P/E ratio?

Orasure Technologies Inc.'s P/E ratio is -4.6.

Orasure Technologies Inc.

NASDAQ · OSUR
$4.32+0.15(+3.60%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Orasure Technologies Inc.'s future dividend policy...
Alpha Chat Insight

Orasure Technologies Inc. trades at a P/E of -4.6 (undervalued) with modest ROE of -18.3%.

Ask for details

Company Overview

Orasure Technologies Inc. is a biotechnology company primarily focused on developing point-of-care diagnostic testing and specimen collection devices. Known for its innovation in oral fluid diagnostics, Orasure provides critical solutions in the healthcare sector. Their product portfolio includes diagnostic tests for infectious diseases, such as HIV and Hepatitis C, leveraging easy-to-use, rapid results that are essential for timely medical interventions. Additionally, Orasure offers services and tools for the life sciences, including molecular sample collection and stabilization products utilized in genetic and microbiome research. The company's products serve a diverse range of sectors, including hospitals, clinics, and public health organizations, contributing significantly to both disease prevention and management. Headquartered in Bethlehem, Pennsylvania, Orasure Technologies plays a pivotal role in advancing public health infrastructure by offering reliable, user-friendly diagnostic tools that empower healthcare providers and patients alike. In the broader market context, Orasure addresses the growing demand for at-home and rapid testing solutions, which have become increasingly crucial components of modern healthcare systems worldwide.

CEOMs. Carrie Eglinton Manner
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees501

Company Statistics

FY 2025

Profile

$317.46MMarket Cap
$115.02MRevenue
0.00Shares Out
501Employees

Margins

41.90%Gross
-47.22%EBITDA
-59.23%Operating
-56.15%Pre-Tax
-59.76%Net

Valuation

-4.62P/E
0.93P/B
2.76EV/Sales
-2.42EV/EBITDA
-5.96P/FCF

Growth (CAGR)

-33.29%Rev 3Yr
-7.70%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-15.57%ROA
-18.30%ROE
-15.43%ROIC

Financial Health

$199.28MCash & Cash Equivalents
$-136.94MNet Debt
18.29%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Orasure Technologies Inc. (ticker: OSUR) is a company listed on NASDAQ in the Healthcare sector (Medical Instruments & Supplies). It has approximately 501 employees. Market cap is $317M.

The current price is $4.32 with a P/E ratio of -4.62x and P/B of 0.93x.

ROE is -18.30% and operating margin is -59.23%. Annual revenue is $115M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Orasure Technologies Inc. (OSUR) Stock Forecast 2026 $4.32 — Price, Financials & Analyst Targets | Alpha Lenz